Acute stroke therapy trials: problems in patient accrual.
نویسندگان
چکیده
منابع مشابه
Acute stroke therapy trials: problems in patient accrual.
Temple University Hospital participated in a multicenter acute stroke trial but enrolled only one patient out of 192 screened over 2 years; other centers had similar difficulty in patient recruitment. We analyzed our screening data to determine which enrollment criteria created difficulties in recruitment and whether the problem was attributable to any single criterion or to combinations of cri...
متن کاملInnovative Designs in Acute Stroke Therapy Trials
More than 74 0001 patients with acute ischemic stroke have been randomized into clinical trials over the past 35 years to investigate new therapies.1 Only one treatment, thrombolysis with recombinant tissue plasminogen activator, has emerged from these investigations.2 Efforts to establish acute neuroprotectant therapies have yet to succeed.3,4 Have we squandered our resources? Has methodologic...
متن کاملAccrual monitoring in cardiovascular trials
Objective To provide brief guidance on how to design accrual monitoring activities in a clinical trial protocol. Setting Two completed clinical trials that did not achieve the planned sample size, the Cost of Strategies After Myocardial Infarction (COSTAMI) trial and the Biventricular Pacing After Cardiac Surgery (BiPACS) trial. Design A Bayesian monitoring tool, the constant accrual model,...
متن کاملTrials of Trials in Acute Ischemic Stroke
Afew years ago, a distinguished colleague and expert in stroke told me, "When we have a treatment for stroke, we will know it" (R. Siekert, personal communication). I agree with this insightful comment, but I also wonder how we will know. Because stroke is a very complex condition with a number of clinical variables that compound care and influence outcome, it is unlikely that any therapy will ...
متن کاملAccrual strategies for phase I trials with delayed patient outcome.
Phase I dose-finding trials typically are conducted using adaptive rules that select dose levels for successive patient cohorts based on the outcomes of patients treated previously in the trial. When patient outcome cannot be observed immediately after treatment, the problem arises of how to deal with new patients while waiting to observe the current patient cohort's outcomes. We consider two a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Stroke
سال: 1988
ISSN: 0039-2499,1524-4628
DOI: 10.1161/01.str.19.8.950